企業プロフィール
T2 Biosystems 株価・ニュース・カタリスト
- ティッカー:
- TTOO
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
0.00 USD (-50.00%)
終値
最終更新: 2026年8月17日
—
時価総額
株価変動の要因
As of Aug 17, 2026, TTOO closed down 50.0% at $0.0005. No new same-company headline was identified in the current news window.
企業概要
事業概要
T2 Biosystems is a medical diagnostics company focused on rapid pathogen detection and bloodstream infection testing. Its business is centered on delivering fast diagnostic information to clinical settings.
所在地とセクター分類
T2 Biosystems is headquartered in the United States and listed on NASDAQ. It sits in medical diagnostics rather than biotechnology therapeutics.
ビジネスモデルの特徴
The company depends on test adoption, hospital utilization, and commercialization execution in a challenging diagnostics market. Investors usually watch sales, reimbursement, and operating discipline.
バイオ業界での位置付け
T2 Biosystems belongs to the diagnostics infrastructure layer of healthcare. It is not a drug developer, but it matters to clinical workflow because rapid testing can change treatment decisions.
今後のカタリスト
- T2 Biosystems is a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。